PET/SPECT核素心肌显像对存活心肌检测的研究进展

韩梦月; 谢锋; 吴天慧; 李雪; 嘉宝

doi:10.13201/j.issn.1001-1439.2020.09.003

PET/SPECT核素心肌显像对存活心肌检测的研究进展

- 辽宁省人民医院核医学科(沈阳, 110000)

详细信息

通讯作者: 谢锋,E-mail:17824930953@163.com

中图分类号: R541.4

收稿日期: 2020-04-15

Radionuclide myocardial imaging evaluates the survival myocardium

- Department of Nuclear Medicine, Liaoning Provincial People's Hospital, Shenyang, 110000, China

More Information

Corresponding author: XIE Feng, E-mail: 17824930953@163.com

Received Date: 15 April 2020

摘要

摘要: 核素心肌显像是心脏功能检查的方法之一,可以对心肌存活进行评估,了解缺血或梗死心肌的具体情况。正电子发射断层成像术(PET)及新型半导体单光子发射计算机断层成像术(SPECT)心肌血流绝对定量分析,为冠状动脉微循环病变的诊断提供重要依据,对缺血性心脏病及特殊人群心肌缺血的早期诊断、临床分级及治疗具有重要意义。
- 冠状动脉疾病 /
- 存活心肌 /
- 正电子发射断层成像术 /
- 单光子发射计算机断层成像术
Abstract: Radionuclide myocardial imaging is one of the methods widely used in cardiac function examination and can evaluate the survival myocardium of patients,and understand the ischemic or infarcted myocardium.The absolute quantitative analysis of myocardial blood flow by PET and new semiconductor SPECT provides important basis for the diagnosis of coronary microcirculation disease,and is of great significance for the early diagnosis,clinical grading and treatment of ischemic heart disease(IHD) and special population.
- coronary artery disease /
- viable myocardium /
- positron emission tomography /
- single-photon emission computed tomography

HTML全文

参考文献(38)

[1]	Cortigiani L,Bigi R,Sicari R.Is viability still viable after the STICH trial?[J].Eur Heart J Cardiovasc Imaging,2012,13(3):219-26.
[2]	Arrighi JA,Dilsizian V.Multimodality imaging for assessment of myocardial viability:nuclear,echocardiography,MR,and CT [J].Curr Cardiol Rep,2012,14(2):234-243.
[3]	Sharir T,Germano G,Kang X,et al.Prediction of myocardial infarction versus cardiac death by gated myocardial perfusion SPECT:Risk stratification by the amount of stress-induced ischemia and the poststress ejection fraction[J].J Nucl Med,2001,42(6):831-837.
[4]	林振宇.核素心肌灌注显像在冠心病中的应用进展[J].心血管病学进展,2013,34(5):626-630.
[5]	高玲,贾鹏,李爱梅.核素心肌灌注显像测量心肌梗死大小临床应用分析[J].山西医药杂志(下半月版),2011,40(20):1005-1006.
[6]	黄中柯,楼岑,史国华,等.99mTc-MIBI和18F-FDG双核素同步显像在心肌梗死诊疗中的价值[J].浙江大学学报(医学版),2010,39(5):530-533.
[7]	Tillisch J,Brunken R,Marshall R,et al.Reversibility of cardiac wall-motion abnormalities predicted by positron tomography[J].N Engl J Med,1986,314(14):884-888.
[8]	Ling LF,Marwick TH,Flores DR,et al.Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction:inducible ischemia versus hibernating myocardium[J].Circ Cardiovasc Imaging,2013,6(3):363-372.
[9]	The task force on myocardial revascularization of the European Society of Cardiology(ECS) and the European Association for Cardio-thoracic Surgery(EACTS).Guidelines on myocardial revascularization[J].Eur Heart J,2010,31(20):2501-2555.
[10]	Nekolla SG,Martinez-Moeller A,Saraste A.PET and MRI in cardiac imaging:from validation studies to integrated applications[J].Eur J Nucl Med Mol Imaging,2009,36(Suppl 1):121-130.
[11]	Todaica A,Brunner S,Boning G,et al.68Ga-Albumin-PET in the monitoring of left ventricular function in murine models of ischemic and dilated cardiomyopathy:comparison with cardiac MRI[J].Mol Imaging Biol,2013,15(4):441-449..
[12]	Handa N,Magata Y,Mukai T,et al.Quantitative FDG-uptake by positron emission tomography in progressive hypertrophy of rat hearts in vivo[J].Ann Nucl Med,2007,21(10):569-576.
[13]	Anavekar NS,Chareonthaitawee P,Narula J,et al.Revascularization in patients with severe left ventricular dysfunction:is the assessment of viability still viable?[J].J Am Coll Cardiol,2016,67(24):2874-2887.
[14]	翟光耀,王建龙,刘宇扬,等.18F-FDG PET/CT心肌代谢显像和侧支循环形成对于冠状动脉慢性闭塞性病变心功能预后价值的比较分析[J].中华医学杂志,2018,98(17):1342-1346.
[15]	杨易剑,侯翠红,田丛娜,等.18F-氟代脱氧葡萄糖心肌代谢显像探测左心室室壁瘤的存活心肌及其合并室性心律失常对患者长期预后的影响[J].中国循环杂志,2015,(12):1152-1156.
[16]	盖婉丽,武萍,梁云亮,等.PET心肌血流绝对定量对非阻塞性冠状动脉微血管疾病的诊断及危险因素评估[J].中华核医学与分子影像杂志,2019,39(8):478-483.
[17]	Vasu S,Bandettini WP,Hsu LY,et al.Regadenoson and adenosine are equivalent vasodilators and are superior than dipyridamole-a study of first pass quantitative perfusion cardiovascular magnetic resonance[J].J Cardiovasc Magn Reson,2013,15:85.
[18]	Watkins S,McGeoch R,Lyne J,et al.Validation of magnetic resonance myocardi-al perfusion imaging with fractional flow reserve for the detection of significant coronary heart disease[J].Circulation,2009,120(22):2207-2213.
[19]	Hsu TH,Huang WS,Chen CC,et al.Left ventricular systolic and diastolic dyssynchrony assessed by phase analysis of gate SPECT myocardial perfusion imaging:a comparison with speckle tracking echocardiography [J].Ann Nucl Med,2013,27(8):764-771.
[20]	Lester D,El-Hajj S,Farag AA,et al.Prognostic value of transient ischemic dila-tion with regadenoson myocardial perfusion imaging[J].J Nucl Cardiol,2016,23(5):1147-1155.
[21]	Klocke FJ,Baird MG,Lorell BH,et al.ACC/AHA/ASNC guide lines for the cardiac radionuclide imaging-Exeactive Sun mary:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines[J].J Am Coll Cardiol,2003,42(7):1318-1333.
[22]	Underwood SR,Anagnostopoulos C,Cerqueira M,et al.Myocardial perfusion scintigraphy:the evidence[J].Eur J Nucl Med Mol Imaging,2004,31(2):261-291.
[23]	张琳,严松彪,陈晖,等.运动负荷99mTc-MIBI SPECT心肌灌注显像对左心室射血分数>45%的怀疑心肌缺血患者的预后价值[J].解放军医学院学报,2017,38(11):1018-1021,1025.
[24]	李勇,张海山,胡文强,等.ATP负荷-(99m)Tc-MIBI门控心肌SPECT显像在冠状动脉临界病变危险分层中的价值[J].中国动脉硬化杂志,2018,26(6):626-632.
[25]	Wackers FJ,Young LH,Inzucchi SE,et al.Detection of silent myocardial ischemia in asymp-tomatic diabetic subjects:the DIAD study[J].Diabetes Care,2004,27(8):1954-1961.
[26]	Zhang L,Li H,Zhang S,et al.Silent myocardial ischemia detected by single photon emission computed tomography (SPECT) and risk of cardiac events among asymptomatic patients with type 2 diabetes:a meta-analysis of prospective studies[J].J Diabetes Complications,2014,28(3):413-418.
[27]	Cremer P,Hachamovitch R,Tamarappoo B.Clinical decision making with myocardial perfusion imaging in patients with known or suspected coronary artery disease [J].Semin Nucl Med,2014,44(4):320-329.
[28]	赵培宏,李卫萍.门控SPECT心肌灌注显像定量分析在冠心病及相关疾病中的应用进展[J].心血管病学进展,2018,39(3):365-369.
[29]	马荣政,王蒙,张宗耀,等.无完整物理校正对多针孔CZT-SPECT进行心肌血流绝对定量的影响[J].中华核医学与分子影像杂志,2019,39(12):720-725.
[30]	Yancy CW,Jessup M,Bozkurt B,et al.2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA guideline for the management of heart failure:a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America[J].Circulation,2017,136(6):e137-e161.
[31]	Beanlands RS,Youssef G.Diagnosis and prognosis of coronary artery disease:PET is superior to SPECT:Pro[J].J Nucl Cardiol,2010,17(4):683-695.
[32]	Knesaurek K,Machac J.Comparison of 18F SPECT with PET in myocardial imaging:a realistic thorax-cardiac phantom study[J].BMC Nucl Med,2006,6:5.
[33]	汪娇,李剑明,李帅,等.PET/CT与SPECT检测心肌存活中影响因素与功能参数的对比研究[J].中国实用医刊,2016,43(13):23-26.
[34]	张颖,田毅,张晓丽,等.门控心肌灌注/代谢显像动态评估小型猪室壁瘤模型左心室功能及心室重建[J].中华核医学与分子影像杂志,2019,39(7):420-422.
[35]	李树恒,方纬,孙晓昕,等.冠状动脉左前降支慢性完全闭塞病变中侧支循环与心肌存活的心肌放射性核素显像研究[J].中国循环杂志,2017,32(4):343-347.
[36]	Tsai JP,Yun CH,Wu TH,et al.A meta-analysis comparing SPECT with PET for the assessment of myocardial viability in patients with coronary artery disease[J].Nucl Med Comm,2014,35(9):947-954.
[37]	Cerqueira MD.Diagnosis and prognosis of coronary artery disease:PET is superior to SPECT:Con [J].J Nucl Cardiol,2010,17(4):678-682.
[38]	Allman KC.Noninvasive assessment myocardial viability:current status and future directions[J].J Nucl cardiol,2013,20(4):618-637.